Aptamer partners with Hong Kong biotech to develop targeted gene therapies
UK based, Aptamer Group, and Hong Kong headquartered, BaseCure Therapeutics, are paring up on the development of Optimer-targeted gene therapies.
Archives for January 31, 2023
US market gets first biosimilar to AbbVie’s Humira
Amgen is launching Amjevita, or adalimumab-atto, a biosimilar to AbbVie’s Humira, in the US; it is the first such biosimilar to the blockbuster drug in that market.